RadNet, Inc. Stockholders' Equity Attributable to Noncontrolling Interest
RadNet, Inc. (RDNT) had Stockholders' Equity Attributable to Noncontrolling Interest of $297.96 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity Attributable to Noncontrolling Interest $297.96M.
- 2026-03-31: Stockholders' Equity Attributable to Noncontrolling Interest $272.16M.
- 2025-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $266.00M.
- 2025-09-30: Stockholders' Equity Attributable to Noncontrolling Interest $255.42M.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2026-06-30 | $297.96M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $272.16M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $266.00M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $255.42M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $246.95M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $238.38M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $231.10M 10-K · filed 2026-03-02 |
| 2024-09-30 | $224.32M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $211.87M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $204.37M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $182.66M 10-K · filed 2025-03-03 |
| 2023-09-30 | $177.26M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $167.84M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $165.18M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $158.46M 10-K · filed 2024-02-29 |
| 2022-09-30 | $145.38M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $139.20M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $122.60M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $117.25M 10-K · filed 2023-03-01 |
| 2021-09-30 | $114.54M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $102.22M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $97.00M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $92.56M 10-K · filed 2022-03-01 |
| 2020-09-30 | $88.92M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $85.45M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $83.81M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $81.45M 10-K · filed 2021-03-16 |
| 2019-09-30 | $80.41M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $78.51M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $77.64M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $73.07M 10-K · filed 2020-03-16 |
| 2018-09-30 | $26.98M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $37.63M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $36.72M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $8.37M 10-K · filed 2019-03-18 |
| 2017-09-30 | $8.09M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $6.73M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $3.43M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $3.57M 10-K · filed 2018-03-19 |
| 2016-09-30 | $3.65M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $3.77M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $4.02M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $3.88M 10-K · filed 2017-03-17 |
| 2015-09-30 | $3.62M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $1.97M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $1.95M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $2.34M 10-K · filed 2016-03-15 |
| 2014-09-30 | $2.05M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $2.31M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $2.21M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $2.29M 10-K · filed 2015-03-16 |
| 2013-09-30 | $2.19M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $2.10M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $2.03M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $634.00K 10-K · filed 2014-03-17 |
| 2012-09-30 | $708.00K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $797.00K 10-Q/A · filed 2012-08-30 |
| 2012-03-31 | $882.00K 10-Q · filed 2012-05-10 |
| 2011-12-31 | $949.00K 10-K · filed 2013-03-18 |
| 2011-09-30 | $108.00K 10-Q · filed 2011-11-09 |
| 2011-06-30 | $139.00K 10-Q · filed 2011-08-09 |
| 2010-12-31 | $57.00K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |